As of 2025-07-04, the EV/EBITDA ratio of Albireo Pharma Inc (ALBO) is -5.66. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALBO's latest enterprise value is 693.41 mil USD. ALBO's TTM EBITDA according to its financial statements is -122.48 mil USD. Dividing these 2 quantities gives us the above ALBO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 12.8x | 10.5x |
| Forward P/E multiples | 11.9x - 20.6x | 16.2x |
| Fair Price | (59.54) - (64.85) | (68.24) |
| Upside | -234.8% - -246.9% | -254.6% |
| Date | EV/EBITDA |